Deregulation of Wnt signalling in AD could be mediated by different mechanisms; elevation of Wnt antagonists, such as Dkk1, or down-regulation of key Wnt components such as Wnt proteins or their receptor Frizzled (Fzd) [16]. The gene discussed is DKK1; the disease is Alzheimer disease.